Testosterone production is dependent on cholesterol transport within the mitochondrial matrix, an essential step mediated by a protein complex containing the steroidogenic acute regulatory (STAR) protein. In steroidogenic Leydig cells, Star expression is hormonally regulated and involves several transcription factors. NR2F2 (COUP-TFII) is an orphan nuclear receptor that plays critical roles in cell differentiation and lineage determination. Conditional NR2F2 knockout prior to puberty leads to male infertility due to insufficient testosterone production, suggesting that NR2F2 could positively regulate steroidogenesis and Star expression. In this study we found that NR2F2 is expressed in the nucleus of some peritubular myoid cells and in interstitial cells, mainly in steroidogenically active adult Leydig cells. In MA-10 and MLTC-1 Leydig cells, small interfering RNA (siRNA)-mediated NR2F2 knockdown reduces basal steroid production without affecting hormone responsiveness. Consistent with this, we found that STAR mRNA and protein levels were reduced in NR2F2-depleted MA-10 and MLTC-1 cells. Transient transfections of Leydig cells revealed that a À986 bp mouse Star promoter construct was activated 3-fold by NR2F2. Using 5 0 progressive deletion constructs, we mapped the NR2F2-responsive element between À131 and À95 bp. This proximal promoter region contains a previously uncharacterized direct repeat 1 (DR1)-like element to which NR2F2 is recruited and directly binds. Mutations in the DR1-like element that prevent NR2F2 binding severely blunted NR2F2-mediated Star promoter activation. These data identify an essential role for the nuclear receptor NR2F2 as a direct activator of Star gene expression in Leydig cells, and thus in the control of steroid hormone biosynthesis.
INTRODUCTION
The steroid hormone testosterone plays a key role in the development and function of male reproduction. Its production is mainly controlled by the hypothalamic-pituitary-gonadal axis. The gonadotropin-releasing hormone, produced by the hypothalamus, stimulates production and secretion of luteinizing hormone (LH) and follicle-stimulating hormone by pituitary gonadotroph cells. Luteinizing hormone then stimulates Leydig cell testosterone synthesis by binding to its G protein-coupled receptor (LHR), leading to increased cAMP production, and ultimately activation of steroidogenesis [1] . Cholesterol transport from the outer to the inner mitochondrial membrane is the rate-limiting step in steroidogenesis. This tightly controlled process depends on the concerted action of a protein complex, the transduceosome [2] [3] [4] , which includes the steroidogenic acute regulatory (STAR) protein [5, 6] . Given the importance of STAR in steroidogenesis, many efforts have been made to understand the complex regulation of Star gene expression. It is well known that the major hormonal regulator of Star mRNA levels in Leydig cells is LH through stimulation of cAMP-dependent pathways [7] . Activation of this pathway stimulates the expression of some immediate-early response genes, such as NR4A1 (NUR77) [8, 9] , and the phosphorylation of many transcription factors, including NR5A1 (SF1) [10] [11] [12] and GATA4 [13] [14] [15] [16] , ultimately leading to increased Star gene expression. Although these and several other transcription factors, including CREB [10] , AP1 family members [17] , and C/EBPb [18, 19] , have been identified as important regulators of Star transcription, additional transcription factors are likely involved.
Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII, also known as NR2F2) is an orphan nuclear receptor that plays critical roles during development [20, 21] . NR2F2 mediates these effects by regulating gene expression via binding to direct-repeat motifs, with a preference for a direct repeat separated by one nucleotide (DR1) [21] [22] [23] [24] . NR2F2 is expressed in several tissues, including limbs, stomach, diaphragm, uterus, heart, and endothelial cells, where it regulates cell growth and differentiation as well as organogenesis [20] . Not surprisingly, global Nr2f2 inactivation leads to embryonic lethality before Embryonic Day 10.5 (E10.5) due to defects in angiogenesis and heart development [25] . However, haploinsufficiency for NR2F2 in female mice results in a significant decrease in fecundity due to a reduction of progesterone synthesis [26] . This reduction was also accompanied by a decrease in the expression of steroidogenic enzyme-encoding genes, including Star, Cyp11a1, and Hsd3b1 [26] .
NR2F2 was also found to be involved in Leydig cell function, and thus testosterone production [27] . Indeed, conditional global inactivation of the Nr2f2 gene specifically during prepubertal stages of male development leads to infertility, hypogonadism, and spermatogenetic arrest due to impaired testosterone synthesis [27] . In the postnatal male mouse, the adult Leydig cells (ALCs), which are distinct from the fetal Leydig cells, form during puberty, and their developmental process consists of multiple steps: stem Leydig cells, progenitor Leydig cells, immature Leydig cells, and mature Leydig cells [28, 29] . In the time-conditional Nr2f2 À/À male mice it was demonstrated that ALC differentiation was arrested at the progenitor cell stage, and consequently the expression of some steroidogenic genes (Cyp11a1, Hsd3b1, Cyp17a1) was decreased [27] . However, it remains unknown whether NR2F2 directly regulates expression of these steroidogenic genes. In the present study we found that the Star gene is a direct target for NR2F2 in Leydig cells, and it acts through a previously uncharacterized DR1-like element located in the proximal promoter region.
MATERIALS AND METHODS

Chemicals
Forskolin (FSK) was purchased from Sigma-Aldrich Canada (Oakville, ON).
Immunohistochemistry
Immunohistochemistry to detect NR2F2 was performed as described previously [8] on testis sections from CD-1 mice from E14.5, E18.5, and E19.5, and Postnatal Days 0, 2, 5, 10, and 36 (P0, P2, P5, P10, and P36). The NR2F2 immunolocalization was done using an anti-NR2F2 antiserum (1:100; R&D Systems, Minneapolis, MN). For double immunodetection, the counterstaining with hematoxylin following NR2F2 detection was omitted and replaced with incubation with an anti-CYP17A1 antiserum (1:200; C-17; Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 258C. Samples were washed twice with 13 PBS for 10 min each time, and alkaline phosphatase (ALKP)-conjugated secondary antibodies (1:1000; Sigma-Aldrich) were added and incubated for 1 h at 258C. Final revelation was done using ALKP revelation solution (Tris-HCl 0.1 M, pH 9.2; 1 mM levamisole; naphthol 0.04%; and Fast Blue BB diazonium salt 0.2% [Sigma-Aldrich]). Negative controls corresponded to the same procedures, with the omission of anti-NR2F2 antiserum (data not shown). All experiments were conducted according to the Canadian Council for Animal Care and have been approved by the Animal Care and Ethics Committee of Laval University (protocol no. 2009011).
Immunofluorescence
MA-10 cells (250 000 cells) were plated on glass coverslip dishes coated with poly-L-lysine (200 lg/ml). Two days later, cells were fixed in cold methanol, permeabilized in 0.1% Triton X-100 in PBS, and blocked in PBS with 1% bovine serum albumin (BSA) þ 10% goat serum for 30 min with agitation. Cells were then washed with 13 PBS three times for 5 min at room temperature with agitation. NR2F2 was detected using a mouse anti-NR2F2 antiserum (R&D Systems) in 13 PBS þ 1% BSA overnight at 48C with agitation. The next day, cells were washed with 13 PBS and incubated with a goat anti-mouse immunoglobulin G (IgG) conjugated with Alexa Fluor 488 (Life Technologies, Burlington, ON, Canada) in 13 PBS with 1% BSA for 1 h at room temperature. Next, cells were washed and incubated with 1 lM CellTracker (C3452; Life Technologies) reagent in 13 PBS for 30 min at 378C. Cells were washed, and the glass coverslips were put on a microscope slide with Slow Fade Gold Antifade Reagent (S36936; Life Technologies). The microscope slides were kept at 48C until images were obtained using the microscope Axioskop2 Plus (Carl Zeiss Canada Ltd., Toronto, ON) and the Image-Pro Plus software (MediaCybernetics, Rockville, MD).
Small Interfering RNA Transfections
MA-10 and MLTC-1 Leydig cells were transfected with 150 nM small interfering RNA (siRNA) directed against NR2F2 (5 0 -ACU GGC CAU AUA UGG CAA UUC AAU A-3 0 ) or a control nontargeting siRNA (Life Technologies) for 48 h using the jetPRIME Transfection Reagent according to manufacturer's protocol for siRNA transfection (PolyPlus, Illkirch, France). Less than 10% difference in NR2F2 expression was observed between the scrambled siRNAs and no siRNA (data not shown). In some experiments, MA-10 and MLTC-1 Leydig cells were treated with 10 lM FSK or vehicle (dimethyl sulfoxide [DMSO] ) for 4 h prior to harvesting.
Protein Purification and Western Blots
Nuclear proteins were obtained from three different Leydig cell lines (MA-10, MLTC-1, and TM3) as described previously [8] . After siRNA and FSK treatments (see above), MA-10 and MLTC-1 Leydig cells were rinsed twice with ice-cold PBS, and whole lysates or nuclear proteins were prepared as described previously [8] . Protein concentrations were estimated using standard Bradford assay. Total (40 lg) and nuclear (15 lg) protein extracts were boiled 10 min in a denaturing loading buffer, fractionated by SDS-PAGE, and transferred onto nitrocellulose membrane (Bio-Rad, Mississauga, ON). Immunodetection was performed using a horseradish peroxidase-linked whole-antibody approach according to the manufacturer's instructions (Amersham ECL and ECL Prime Western Blotting Detection Reagents; GE Healthcare Lifesciences, Baie d'Urfé, QC). Detection of NR2F2, aTUBULIN, STAR, and LAMIN-B proteins was performed using a monoclonal anti-NR2F2 antiserum (1:1000; R&D Systems), a monoclonal anti-aTUBULIN antiserum (1:50 000; Sigma-Aldrich), an anti-STAR antiserum (1:500; FL-285; Santa Cruz Biotechnology), and an anti-LAMIN-B antiserum (1:1000; C-20; Santa Cruz Biotechnology), respectively. Western blotting was used to confirm that the monoclonal anti-NR2F2 specifically recognizes recombinant NR2F2 but not NR2F1 (COUP-TFI; data not shown).
Progesterone and Testosterone Quantification
Enzyme-linked immunosorbent assays (ELISAs) for progesterone and testosterone quantification were performed as recommended by the manufacturer (Cayman Chemical Company, Ann Arbor, MI). Following siRNA treatment (see above), the culture medium was replaced with serum-free medium in the presence of vehicle (DMSO) or 10 lM FSK for 4 h. This medium was then transferred to 1.5-ml tubes and stored at À808C until ELISAs were performed. For basal progesterone and testosterone quantification (without FSK stimulation), 50 ll of medium was diluted with 950 ll of EIA buffer (1:20), 50 ll of which was then used in the ELISA. For progesterone quantification in FSK-stimulated cells, 20 ll of the medium was diluted with 980 ll of EIA buffer (1:50), 50 ll of which was subsequently used in the ELISA. For testosterone quantification in FSK-stimulated MLTC-1 cells, a 1:50 000 dilution was used.
Plasmids
The À986 bp murine Star luciferase promoter construct has been described previously [16] . Deletions of the Star promoter to À204, À144, À131, À95, and À81 bp were previously described [8] . The minimal construction to À54 bp was obtained by PCR using the following primers: forward, 5 0 -GAT CCC CTT CCA CGG GAA GCA TTT AAG GCA GCG CAC TTG ATC TGC GCC ACA GCT GCA GGA CTC AGG GGT AC-3 0 ; and reverse, 5 0 -CC CTG AGT CCT GCA GCT GTG GCG CAG ATC AAG TGC GCT GCC TTA AAT GCT TCC CGT GGA AGG G-3 0 . All promoter fragments were cloned into a modified pXP1 luciferase reporter plasmid [30] . The À986 bp Star reporter constructs harboring inactivating mutations in each or both half-sites of the DR1-like element were generated using the QuikChange XL mutagenesis kit (Stratagene, La Jolla, CA) with the following oligonucleotides (mutated nucleotides are underlined and lowercase): mutation at À108 bp sense, 5 0 -GGA TGA GGC AAT CAT TCC ATa aTT GAC CCT CTG CAC AAT GAC-3 0 , antisense, 5 0 -GTC ATT GTG CAG AGG GTC AAt tAT GGA ATG ATT GCC TCA TCC-3 0 ; mutation at À101 bp sense, 5 0 -GCA ATC ATT CCA TCC TTG ACa aTC TGC ACA ATG ACT GAT GAC-3 0 , and antisense, 5 0 -GTC ATC AGT CAT TGT GCA GAt tGT CAA GGA TGG AAT GAT TGC-3 0 ; and the double mutation generated using the reporter mutated at À101 bp as template sense, 5 0 -GCA CTG CAG GAT GAG GCA ATC ATT CCA Taa TTG ACa aTC TGC ACA ATG AC-3 0 , and antisense, 5 0 -GTC ATT GTG CAG Att GTC AAt tAT GGA ATG ATT GCC TCA TCC TGC AGT GC-3 0 . The À1003 bp Fdx1 and À820 bp Cyp11a1 promoters were obtained by PCR from mouse genomic DNA using the following primers: Fdx1 forward, 5
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TGC AGT GCT TT-3 0 , and reverse, 5 0 -CCA TAA CCC TGT CGG AAG GT-3 0 ; Cyp11a1 forward, 5 0 -AGG GAT CCT CTG TAA GTC CAA GAT TTG ACA C-3 0 , and reverse, 5 0 -CTG GTA CCC CAC GAC TGC CAC TTC CTG CTG C-3 0 . The À1375 bp murine Hsd3b1, murine À287 bp Cyp19, and rat À447 bp Cyp11a1 luciferase promoter constructs have been described previously [16, 31, 32] . The mouse NR5A1 (SF1) expression vector has been described previously [16] , and the rat NR4A1 (NUR77) expression vector [33] was provided by Dr. Jacques Drouin (Laboratoire de Génétique Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, QC). The mouse NR2F2 expression vector [25] was obtained from Dr. Ming Tsai (Baylor College of Medicine, Houston, TX). All plasmids were verified by sequencing (Centre de génomique de Québec, CHUL Research Centre, Québec City, QC).
Cell Culture, Transfections, and Reporter Assays
Mouse MA-10 Leydig cells [34] , provided by Dr. Mario Ascoli (University of Iowa, Iowa City, IA), and mouse TM3 Leydig cells (ATCC, Manassas, VA) were grown in Dulbecco modified Eagle medium (DMEM)/F12 medium supplemented with serum, 2.438 g/L sodium bicarbonate, and 3.57 g/L HEPES. For MA-10 Leydig cells, 15% horse serum was added to medium, and a mix of 5% horse serum and 2.5% fetal bovine serum was added for TM3 Leydig cells instead. Mouse MLTC-1 Leydig cells (ATCC) were grown in DMEM supplemented with 3.7 g/L HEPES and 10% fetal bovine serum. Additionally, 50 mg/L penicillin and streptomycin sulfates were added to these media and all cells were maintained at 378C in 5% CO 2 . MA-10 and MLTC-1 cells were transfected using the calcium-phosphate coprecipitation method, and lysates were analyzed as previously described [8, 35] . Data reported represent the average of at least three experiments, each performed in duplicate.
RNA Isolation and Real-Time PCR
Following siRNA treatment, RNA isolation, cDNA synthesis, and quantitative RT-PCR were performed as previously described [8] . Briefly, cells were cultured in serum-free medium containing either vehicle or 10 lM FSK for 4 h prior to RNA isolation.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (ChIP) assays were performed essentially as described previously [36] with some modifications. Briefly, MA-10 Leydig cells were incubated with either vehicle (DMSO) or 10 lM FSK for 4 h prior to 1% formaldehyde fixation at 208C for 10 min. After harvesting in PBS, pelleted cells were washed for 10 min at 48C each time with Buffer I (0.25% Triton X-100; 10 mM ethylene diamine tetraacetic acid [EDTA]; 0.5 mM ethylene glycol tetraacetic acid [EGTA]; and 10 mM HEPES, pH 6.5) and Buffer II (200 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; and 10 mM HEPES, pH 6.5) and protease inhibitors. Then, samples were centrifuged at 8000 rpm for 5 min at 48C. Pellets were resuspended (1% SDS; 10 mM EDTA; 50 mM Tris, pH 8.0; and freshly added protease inhibitors) and incubated on ice for 10 min. Samples were then sonicated with the Misonix S-400 at 80% power and the lysates were centrifuged at 13 000 rpm. Supernatants were diluted and incubated at 48C for 2 h with 30 ll of magnetic beads (Dynabeads; Life Technologies), which were previously blocked (with 0.2 lg/ll sheared salmon sperm DNA and 0.5% BSA in PBS for 1 h at 48C), along with 5 lg of an NR2F2 antiserum (R&D Systems) or nonspecific IgG (Santa Cruz Biotechnology). Precipitates were washed four times in a rotating wheel with ChIP wash buffer (100 mM Tris, pH 7.4; 500 mM LiCl; 1% Igepal [Sigma-Aldrich]; and 1% sodium deoxycholate) for 5 min at 48C, and once again with TE (10 mM Tris, pH 8; and 1 mM EDTA). Precipitates were extracted with freshly prepared elution buffer (1% SDS and 0.1 M NaHCO 3 ). Eluates were kept at 658C overnight with 0.2 M NaCl to reverse the crosslinks. DNA was purified by phenol/chloroform/ethanol and resuspended in 10 mM Tris, pH 8. NR2F2-immunoprecipitated DNA fragments were analyzed by PCR using primers specific for the proximal (À299 bp to À41 bp; forward, 5 0 -TGA TGC ACC TCA GTT ACT GG-3 0 ; reverse, 5 0 -GCT GTG CAT CAT CAC TTG AG-3 0 ) or distal (À3584 bp to À3428 bp; forward, 5 0 -CAT ACG TGC ACT GTC TTA GC-3 0 ; reverse, 5 0 -ACT CCT CCA GTA ACT CCT TC-3 0 ) region of the mouse Star promoter [37] . The PCR reactions were done on a T gradient thermocycler (Biometra; Montreal Biotech, Montreal) using Vent polymerase (New England Biolabs, Whitby, ON) and the following conditions: 5 min at 958C, followed by 40 cycles of denaturation (20 sec at 958C), annealing (30 sec at 578C), and extension (30 sec at 688C). The specificity of PCR products was confirmed by agarose gel electrophoresis and sequencing. Input DNA represents 10% of total DNA used for a ChIP experiment. The ChIP results were confirmed by three separate experiments.
DNA Precipitation Assays
DNA precipitations were performed with 30 ll of streptavidin magnetic beads (Promega, Madison, WI), which were washed twice with 13 B&W buffer (5 mM Tris, pH 7.5; 0.5 mM EDTA; and 1 M NaCl), and then 100 ng of wild-type and mutated double-stranded biotinylated oligonucleotides was bound to the beads in 13 B&W buffer for 1 h at room temperature (beads without oligonucleotides were used as a negative control). Beads were washed twice in 13 B&W buffer, once with 13 binding buffer (5% glycerol; 20 mM Tris, pH 7.5; 1 mM EDTA; 1 mM dithiothreitol; 0.15% Triton X-100; 100 mM NaCl; and 4 mM MgCl 2 ) and blocked with 1% BSA and sperm salmon DNA (0.2 mg/ml) for 1 h at 48C. Bound biotinylated oligonucleotides were then mixed with 10 lg of poly (dI-dC) and 100 lg of nuclear extracts from MA-10 Leydig cells in a total volume of 500 ll of 13 binding buffer with protease inhibitors, and incubated for 2 h (1 h 30 min at 48C and 30 min at room temperature) with rotation, followed by five washes in 13 binding buffer. Bound proteins were then eluted in Western blot loading buffer and analyzed by SDS-PAGE. The following oligonucleotides were biotinylated, annealed with the corresponding nonbiotinylated oligonucleotide, and used as probes: 1) containing the wild-type NR2F2 high-affinity response element (underlined) [24] 
Statistical Analyses
For all single comparisons between two experimental groups, paired Student t-tests were performed. For all statistical analyses, P , 0.05 was considered significant. For multiple group comparisons, statistical analyses were done using one-way ANOVA followed by the Newman-Keuls posttest. All statistical analyses were done using the GraphPad Prism software (GraphPad Sofware Inc., La Jolla, CA).
RESULTS
NR2F2 Is Present in Interstitial/Leydig Cells of the Murine Testis Throughout Life
So far, there is limited information regarding the presence of the NR2F2 protein during mouse testicular development. NR2F2 was reported to be present in the testis, but only E18.5 and P7 were studied [27] . We therefore performed immunohistochemistry on mouse testis sections at different developmental stages (E14.5, E18.5, P0, P2, P5, P10, and P36) and found that NR2F2 is present in the nucleus of interstitial cells at all stages tested (brownish staining in Fig. 1 , identified by solid arrowheads). NR2F2 was also detected in some peritubular cells (arrows in Fig. 1 ). Sertoli cells as well as gonocytes/germ cells were negative at all stages (Fig. 1) . To identify the type of interstitial cells expressing NR2F2, double immunohistochemistry for NR2F2 and CYP17A1, a marker of steroidogenically active Leydig cells, was performed. NR2F2 did not colocalize with CYP17A1 in Leydig cells (solid arrowheads in Fig. 1I ) at E19.5. However, at P36 NR2F2 strongly colocalized with CYP17A1 in Leydig cells (solid arrowheads in Fig. 1J ). Some interstitial cells were also positive for NR2F2 but negative for CYP17A1 (open arrowheads in Fig. 1, I and J).
To identify a cell line expressing NR2F2 for mechanistic and functional studies, we performed Western blot analyses using nuclear proteins from three different mouse Leydig cell lines (MA-10, MLTC-1, and TM3), all corresponding to the ALC population [34, 38] . As shown in Figure 2A , a band of 45 kDa corresponding to NR2F2 was detected in the three Leydig cell lines. We chose the well-characterized MA-10 Leydig cell line for the following experiments. Because these cells strongly express the 5a-reductase enzyme [39, 40] , an enzyme known to be abundant in vivo in immature Leydig cells but virtually MENDOZA-VILLARROEL ET AL. absent in mature and fully functioning Leydig cells [39, 40] , MA-10 cells correspond to immature ALCs. As such, they represent a suitable model for studying the role of NR2F2, which was shown to be essential at the immature stage [27] . Immunofluorescence on MA-10 Leydig cells also confirmed the nuclear localization of endogenous NR2F2 (Fig. 2B ).
NR2F2 Is Necessary for Optimal Steroidogenesis in MA-10 and MLTC-1 Leydig Cells
To determine whether NR2F2 is involved in steroidogenesis in immature Leydig cells, MA-10 Leydig cells were transfected with siRNAs directed against NR2F2 or with nontargeting siRNAs. The cells were then stimulated or not with FSK, a potent activator of adenylate cyclase leading to the production of physiological cAMP concentrations and enhanced steroidogenesis. As shown in Figure 3A , NR2F2 levels were decreased by about 75% in knockdown cells. In these NR2F2-depleted MA-10 cells, basal progesterone production was decreased by 23% and FSK-induced production by 37% (Fig. 3B) . However, the fold stimulation by FSK was not significantly reduced (7.6-fold in control vs. 6.3-fold in NR2F2-depleted cells). Because MLTC-1 Leydig cells produce testosterone, similar experiments were performed in these cells. In NR2F2-depleted MLTC-1 Leydig cells (Fig. 4A) , both basal and FSK-induced progesterone (Fig. 4B) and testosterone (Fig. 4C ) production were significantly decreased. As for MA-10 cells, however, the fold stimulation by FSK was unaffected in NR2F2-deficient MLTC-1 cells. Thus, NR2F2 is important for basal steroidogenesis in MA-10 and MLTC-1 Leydig cells and dispensable for hormonal responsiveness.
NR2F2 Directly Regulates Star Gene Expression
To identify genes regulated by NR2F2, transient transfections were performed in MA-10 Leydig cells using a series of luciferase reporters corresponding to genes expressed in Leydig cells (Fdx1, Hsd3b1, Cyp17a1, Cyp11a1, Cyp19a1, Nr4a1, and Star). Of the reporters tested, only the À986 bp mouse Star promoter was activated in the presence of NR2F2 (Fig. 5A) . A dose-response test was next performed to determine the optimal amount of NR2F2 needed to specifically activate the Star promoter. As shown in Figure 5B , NR2F2 could activate a À986 bp Star reporter at all doses tested (25, 50, 125 , and 250 ng); however, at 250 ng a minimal Star reporter (À54 bp) lacking most critical regulatory elements [1] was significantly activated, suggesting nonspecific effects at that dose (Fig. 5B) . We therefore chose 50 ng of NR2F2 as the optimal dose to significantly and specifically activate the À986 bp Star promoter.
To establish a role for NR2F2 in Star gene expression, MA-10 and MLTC-1 Leydig cells were transfected with siRNAs directed against NR2F2 or with nontargeting siRNAs, treated or not with FSK, and Star mRNA levels were determined by quantitative PCR. Reducing NR2F2 levels in MA-10 cells led Prior to harvesting, cells were incubated with FSK (10 lM) or DMSO for 4 h. A) Western blot analysis was used to assess NR2F2 levels. LAMIN B (LMNB1) was used as loading control. Results shown are representative of three independent experiments. B) Progesterone concentrations were determined by ELISA (ng/ml 6 SEM). *P , 0.05; **P , 0.01. The numbers in the bars correspond to the fold stimulation by FSK.
NR2F2 REGULATES Star EXPRESSION to decreases of 56% and 27% in Star mRNA levels in basal and stimulated conditions, respectively (Fig. 6A) . Similar decreases were observed in NR2F2-depleted MLTC-1 cells (Fig. 6B ). At the STAR protein level, ;30% (MA-10) and ;50% (MLTC-1) reductions were observed for both basal and FSK-treated MA-10 ( Fig. 6C) and MLTC-1 (Fig. 6D ) Leydig cells. Thus, as for steroid production (Figs. 3 and 4) , the fold enhancement by   FIG. 4 . Depletion of endogenous NR2F2 affects progesterone and testosterone in MLTC-1 Leydig cells. Cells were transfected and treated as described in Figure 3 . A) Western blot analysis was used to assess NR2F2 levels. LAMIN B (LMNB1) was used as loading control. Results shown are representative of three independent experiments. Progesterone (B) and testosterone (C) concentrations were determined by ELISA (ng/ml 6 SEM). *P , 0.05; **P , 0.01. The numbers in the bars correspond to the fold stimulation by FSK. FSK of Star mRNA and STAR protein was not reduced when NR2F2 levels were decreased (Fig. 6) .
Next, a series of 5 0 progressive deletions of the Star promoter were generated and tested for NR2F2 responsiveness in MA-10 Leydig cells. As shown in Figure 7A , deletion from À986 to À131 bp did not impair NR2F2 responsiveness. However, deletion constructs to À95, À81, and À54 bp were only weakly activated by NR2F2 (Fig. 7A) . These results 
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indicate that an NR2F2-responsive element is likely located between À131 and À95 bp. In silico analysis of this 36-bp sequence revealed the presence of a previously uncharacterized DR1-like element that could mediate the NR2F2-dependent Star promoter activation (Fig. 7B) . The importance of this DR1-like element was further analyzed by introducing mutations in either or both DR1-like half-sites in the context of the À986 bp Star promoter. As shown in Figure 7 , B (MA-10 Leydig cells) and C (MLTC-1 Leydig cells), mutation of either or both half-sites led to a significant decrease in NR2F2 responsiveness, indicating that the DR1-like element located at À113/À100 bp is necessary for the NR2F2-mediated transactivation of the À986 bp Star reporter in these cells.
Chromatin immunoprecipitation assays were performed next to determine whether NR2F2 is recruited to the proximal Star promoter. Proteins were crosslinked to the chromatin, which was then sheared and immunoprecipitated using an anti-NR2F2 monoclonal antibody. Using PCR, a band of 258 bp (À299 to À41 bp) was detected in the input sample (Fig. 8A,  upper panel, lanes 2 and 4) as well as in the sample immunoprecipitated with the anti-NR2F2 antiserum (Fig. 8A,  upper panel, lane 5) , but not in the IgG control sample (Fig.  8A, upper panel, lane 3) . We did not observe the recruitment of NR2F2 to the distal region of Star promoter at À3.5 kb of the transcription start site (Fig. 8A, lower panel, lane 5) . Similarly, no recruitment was observed when IgG was used (Fig. 8A,  lower panel, lane 3) . NR2F2 is thus recruited to the proximal Star promoter in a native chromatin environment in MA-10 Leydig cells. To confirm that NR2F2 directly binds to the DR1-like element, an in vitro DNA precipitation approach was used. As shown in Figure 8B , NR2F2 was found to bind to oligonucleotides containing a high-affinity DR1 element (Fig.  8B, lane 3) and the DR1-like element from the Star promoter (Fig. 8B, lane 5) , but not to oligonucleotides harboring mutations in these elements (Fig. 8B, lanes 4 and 6) . Because the Star DR1-like element overlaps with a previously characterized NR5A1-binding site [11, 41, 42] , it was not surprising to observe that NR5A1 could bind to the oligonucleotide containing the DR1-like element but not the one containing the high-affinity DR1 element (lower panel of Fig. 8B ). Taken together, these results indicate that NR2F2 directly and specifically binds to the DR1-like element in the proximal Star promoter.
Because the NR2F2 element overlaps with the NR5A1-and NR4A1-binding sites [8] , we tested the possibility that NR2F2 might cooperate with these two nuclear receptors to modulate Star promoter activity. Cotransfections in MA-10 Leydig cells revealed that NR2F2 and NR5A1 have additive effects, whereas no cooperation was observed between NR2F2 and NR4A1 (Fig. 8C) .
DISCUSSION
Many efforts have been deployed to understand the molecular mechanisms involved in the regulation of steroidogenesis that could explain some cases of idiopathic subfertility as well as some cases of disorders of sex development. As a result, critical roles for nuclear receptors in the regulation of genes encoding different proteins involved in steroid biosynthesis, such as STAR, have been revealed. In this study, we identified a role for the nuclear receptor NR2F2 in steroidogenesis through the activation of Star expression in Leydig cells.
NR2F2 as a Dynamic Marker of Leydig Cells
Although NR2F2 is known to be present in the testis [25, 27] , a detailed expression profile in the mouse testis had not been reported previously. Here we found that NR2F2 is present in the nucleus of interstitial cells at all stages tested (embryonic, neonatal, puberty, and adult). Using a wellcharacterized Leydig cell marker (CYP17A1), we determined that the NR2F2-positive interstitial cells at the late fetal stage are not steroidogenically active Leydig cells, but rather undifferentiated mesenchymal cells, which is consistent with data from the rat testis [43] . Some of these mesenchymal cells differentiate into Leydig cells and have been shown to be essential for Sertoli cell proliferation and fetal testis cord development [44] . It is therefore possible that NR2F2 might play a role in the maintenance of mesenchymal cell undifferentiated state and/or the initiation of fetal Leydig cell differentiation without being directly involved in steroidogenesis during fetal life. In the postnatal mouse, many of the interstitial cells were identified as testosterone-producing adult Leydig cells (CYP17A1 positive). NR2F2 could then regulate steroidogenesis during the differentiation process of the adult Leydig cell population.
It has been demonstrated that the adult Leydig cell population does not derive from preexisting fetal Leydig cells, but rather originates from undifferentiated precursor cells [45] , some of which are proposed to be peritubular cells [29, [45] [46] [47] [48] . The identification of the NR2F2 transcription factor as a unique marker of peritubular cells that are not steroidogenic would be consistent with a role for NR2F2 as a regulator of the Leydig stem cell pool renewal and/or differentiation into steroidogenic cells. Moreover, we also identified some interstitial cells that were positive for NR2F2 but negative for CYP17A1. The nature of these cells remains to be established, but some are likely cells from blood vessels known to express NR2F2 [25] , whereas others might represent another source of Leydig stem cells, as proposed by Barsoum et al. [49] and Kilcoyne et al. [50] .
NR2F2 Activates Steroidogenesis by Directly Enhancing Star Expression
Deletion of the Nr2f2 gene at the prepubertal stage in mice results in infertility caused by insufficient testosterone production due to abnormal Leydig cell differentiation and function [27] . However, when Nr2f2 was inactivated in adult mice, androgen production was normal, demonstrating that NR2F2 was not required for the maintenance of mature Leydig cell function in adults [27] . These in vivo mouse data indicate that NR2F2 is essential for Leydig cell differentiation and function up to the progenitor/immature stage but would be dispensable at the mature stage [27] . However, the mechanisms of NR2F2 action remain elusive. NR2F2 could be required for the expression of factors essential for adult Leydig cell differentiation, such as the LH receptor [51, 52] , plateletderived growth factor receptor a [53] , and Patched [54] . NR2F2 could also regulate the expression of genes involved in androgen biosynthesis, because androgen production itself is required for proper differentiation of adult Leydig cells [55] [56] [57] . In agreement with this, our present data support a role for NR2F2 in the regulation of Star gene expression, which encodes a key protein required for steroid hormone biosynthesis [5, 6] .
Because androgen production was affected when the Nr2f2 gene was inactivated at the prepubertal stage, when ALC differentiation is not completed, and not when inactivated at the mature stage [27] , we chose to study NR2F2 function in nonfully differentiated ALC lines, the MA-10 and MLTC-1 lines. Both cell lines retain several characteristics of Leydig cells, including hormone responsiveness [34] , and, as mentioned before, these cells would therefore correspond to immature Leydig cells [39, 40] . Using an siRNA-mediated knockdown approach, we found that NR2F2-depleted MA-10 and MLTC-1 Leydig cells produced significantly less steroids in basal and stimulated conditions than control cells. This reduction in steroidogenesis observed in NR2F2-depleted MA-10 and MLTC-1 cells is thus consistent with in vivo data obtained at the prepubertal stage [27] . Although in the absence of NR2F2 the absolute levels of progesterone/testosterone were decreased NR2F2 REGULATES Star EXPRESSION 9
Article 26 both in unstimulated and FSK-treated MA-10 and MLTC-1 Leydig cells, the fold stimulation by FSK was not reduced. This indicates that NR2F2 is involved in basal steroid production but dispensable for hormone responsiveness. This decrease in progesterone and testosterone production can be explained at least in part by a decrease in Star mRNA and STAR protein levels in NR2F2-depleted MA-10 and MLTC-1 Leydig cells. These results are in agreement with data from Takamoto et al. [26] , who reported a decrease in Star mRNA levels in the gonads of Nr2f2 þ/À female mice. The STAR protein is an essential component of the cholesterol transport machinery, which shuttles cholesterol, the precursor of all steroids, from the outer to the inner mitochondrial membrane, where steroidogenesis is initiated [1, [58] [59] [60] . We found that NR2F2 is directly recruited to a DR1-like element in the proximal Star promoter, a highly conserved region known to contain several critical regulatory elements [61] , and that the integrity of this element is essential for NR2F2 binding and NR2F2-mediated activation. Interestingly, this DR1-like element overlaps with a previously characterized and species-conserved element known to bind the nuclear receptors SF1/NR5A1 [11, 41, 42] and NUR77/NR4A1 [8] . Although all three nuclear receptors (NR2F2, NR5A1, and NR4A1) can bind to this element, the molecular mechanism by which each factor contributes to Star gene expression remains poorly studied. It is possible that each factor is recruited to the promoter based on the physiological conditions. For instance, NR4A1 is normally weakly expressed in Leydig cells, but its expression and recruitment to the Star promoter are significantly increased in response to hormonal stimulation [8] , whereas expression of NR5A1 [8] and NR2F2 (the current study) is not significantly affected by hormonal stimulation. Alternatively, each nuclear receptor might contribute to Star expression in association with distinct subsets of neighboring transcription factors or coactivators, which would favor the recruitment of a specific nuclear receptor. Such a differential recruitment mechanism would therefore contribute to the finetuning regulation of Star expression. Here we found that NR2F2 and NR5A1 (but not NR4A1) had additive effects on the Star promoter. Whether these two nuclear receptors directly interact is unknown.
Contrary to what we describe here, COUP-TF family members have also been proposed as negative regulators of steroidogenesis. For instance, in adrenal cells NR2F1 was found to inhibit NR5A1-dependent activation of the Cyp17a1 promoter by competing with NR5A1 for binding to the repCRS2 element [62] [63] [64] . In bovine glomerulosa cells, overexpression of NR2F1 and NR2F2 suppressed the angiotensin II-mediated induction of Star mRNA and STAR protein [65] . There are also inconsistent data regarding the role of NR2F2 in the female reproductive tissues. NR2F2 was reported to inhibit Star expression in the endometriotic cells [66] . FIG. 8 . NR2F2 is recruited to the Star proximal promoter region and directly binds to the DR1-like element at À106 bp. A) NR2F2 is recruited in vivo to the proximal region of Star promoter. An aliquot (10%) of chromatin preparation before immunoprecipitation (input) was used as positive control. Chromatin was immunoprecipitated with anti-NR2F2 antiserum (aNR2F2). Preimmune rabbit serum (IgG) was used as negative control. A band of 258 bp containing the DR1-like element in the proximal, but not distal, Star promoter was amplified by PCR. Water was used as a negative control for the PCR reaction (PCR (À)). A representative result of three independent experiments is shown. B) NR2F2 directly binds to the DR1-like element in vitro. DNA precipitation assays were performed as described in Materials and Methods using double-stranded biotinylated oligonucleotides containing a high-affinity DR1 element (HA DR1, AGGTCAnAGGTCA) or the DR1-like element in the Star promoter 3 (Star DR1-like), either wild type (WT) or with a mutation that destroys the binding site (Mut) along with nuclear extracts from MA-10 Leydig cells. Western blot analyses were used to detect NR2F2 and NR5A1. Input corresponds to 15 lg of the nuclear extracts used in the DNA precipitation assay. The Western blots shown are representative of three independent experiments. C) NR2F2 cooperates with NR5A1. MA-10 Leydig cells were cotransfected with an empty expression vector (white bar) or expression vectors for NR2F2, NR4A1, or NR5A1 (solid bars), either alone or in combination as indicated along with a À986 bp Star reporter. The number of experiments, each performed in triplicate, is indicated. Results are shown as fold activation over control (6SEM). Different letters indicate statistically significant differences (P , 0.001).
However, Nr2f2 þ/À haploinsufficient female mice have a reduced ability to synthesize progesterone in response to exogenous gonadotropins due to a decrease in the expression of several steroidogenic enzymes important for progesterone synthesis, including Star [26] .
Although NR2F2 was often proposed as a negative regulator of steroidogenesis, this is based solely on the inverse correlation between NR2F1/NR2F2 protein levels and that of STAR, CYP17A1, CYP11A1, HSD2B1, NR5A1, and NR0B1 in human adrenocortical tumors and normal adrenal cortex [63, 64] , as well as in primary cultures of bovine theca cells and human ovary [67, 68] . A similar inverse correlation between Nr2f2 mRNA levels and the mRNA levels of Star, Cyp11a1, and Cyp17a1 in fetal Leydig cells treated with endocrine disruptors was also used to conclude that NR2F2 was a negative regulator of testicular steroidogenesis [43] . In all of these cases, no functional studies were performed. In our functional assays, we consistently found that NR2F2 was an activator of Star transcription in MA-10 and MLTC-1 Leydig cells, which is consistent with in vivo data in the mouse [26, 27] . We also found that NR2F2 cooperates with NR5A1 on the Star promoter. Furthermore, NR2F1 (COUP-TFI) is poorly expressed in the testis [69, 70] , and in agreement with this we were unable to detect the NR2F1 protein in MA-10 Leydig cells by Western blot analysis (data not shown).
In conclusion, our data provide new insights as to the role of NR2F2 in Star transcription, and thus in Leydig cell steroidogenesis. As revealed by genetic data in the mouse, however, NR2F2 is bound to have a broader role in Leydig cell differentiation and function, a role that warrants further investigations.
